US Stocks

Corcept Therapeutics Incorporated

Corcept Therapeutics Inc. discovers, develops and sells drugs for severe metabolic, oncologic, and neuropsychiatric illnesses in the US. The company offers Korlym (mifepristone) for oral administration once a day for treating hyperglycemia secondary to hypercortisolism. Currently, the company is developing relacorilant and nab-paclitaxel to treat patients with advanced ovarian tumors, metastatic castration-resistant prostate cancer, and antipsychotic-induced weight gain, among other conditions.